Rapid Micro Biosystems (RPID) Enterprise Value (2020 - 2026)

Rapid Micro Biosystems has disclosed Enterprise Value across 7 years of filings, most recently posting -$22.9 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$22.9 million, changed 0.37% year-over-year; the trailing twelve-month figure through Mar 2026 was -$22.9 million (changed 0.37% YoY), and the FY2025 annual result was -$18.4 million, up 46.02% from the prior year.
• Enterprise Value came in at -$22.9 million for Q1 2026 at Rapid Micro Biosystems, down from -$18.4 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$18.4 million in Q4 2025 to a low of -$162.2 million in Q1 2022.
• The 5-year median for Enterprise Value is -$50.7 million (2022), against an average of -$63.0 million.
• Across the five-year window, Enterprise Value slumped 109.1% in 2023 and jumped 71.25% in 2025, its largest moves.
• Rapid Micro Biosystems' Enterprise Value stood at -$81.8 million in 2022, then declined by 12.56% to -$92.1 million in 2023, then soared by 63.04% to -$34.0 million in 2024, then jumped by 46.02% to -$18.4 million in 2025, then fell by 24.95% to -$22.9 million in 2026.
• The last three Enterprise Value figures came in at -$22.9 million (Q1 2026), -$18.4 million (Q4 2025), and -$41.2 million (Q3 2025), per Business Quant data.